Stock ScreenerStock IdeasPositive Investor SentimentPositive Investor SentimentInvestor sentiment can often be a leading indicator of stock performance. Sentiment Rating incorporates analyst revisions, insider activity, and short interest.
Stock ScreenerStock IdeasPositive Investor Sentiment
Zen Rating: A + 1 more
Sentiment Rating: A + 1 more
| Ticker | Company | Exchange | Industry | Zen Rating | Market Cap | Price | 1d % | EBITDA | P/E | D/E | Country | DD Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BKTI | BK TECHNOLOGIES CORP | NYSEMKT | Communication Equipment | A | $159.43M | $44.62 | -1.48% | $9.33M | 18.99x | 0.73 | United States | 40 |
| CAPL | CROSSAMERICA PARTNERS LP | NYSE | Oil & Gas Refining & Marketing | B | $906.96M | $23.83 | 1.55% | $147.32M | 45.83x | -21.19 | United States | 4 |
| PLX | PROTALIX BIOTHERAPEUTICS INC | NYSEMKT | Biotechnology | A | $239.56M | $3.07 | -2.28% | $6.52M | 76.75x | 0.70 | Israel | 23 |
| KMDA | KAMADA LTD | NASDAQ | Drug Manufacturers - Specialty & Generic | A | $372.06M | $6.47 | 1.55% | $27.80M | 25.88x | 0.44 | Israel | 45 |
| CCRD | CORECARD CORP | NYSE | Software - Application | A | $151.22M | $19.42 | 0.26% | $10.47M | 28.56x | 0.21 | United States | 37 |
Upgrade to Premium to View More
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
Already have a premium account? Sign In
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.